financetom
Business
financetom
/
Business
/
Veralto Insider Sold Shares Worth $1,387,297, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Veralto Insider Sold Shares Worth $1,387,297, According to a Recent SEC Filing
Jul 31, 2024 2:20 PM

05:00 PM EDT, 07/31/2024 (MT Newswires) -- Jennifer Honeycutt, Director, President and CEO, on July 30, 2024, sold 13,191 shares in Veralto ( VLTO ) for $1,387,297. Following the Form 4 filing with the SEC, Honeycutt has control over a total of 138,546 shares of the company, with 138,546 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1967680/000196768024000115/xslF345X03/wk-form4_1722459154.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Mountain Valley passes test after fixing leak in WV-VA natgas pipe
US Mountain Valley passes test after fixing leak in WV-VA natgas pipe
May 10, 2024
May 10 (Reuters) - U.S. natural gas pipeline venture Mountain Valley Pipeline said on Friday it repaired a segment of pipe that failed a water test earlier in the month and will continue to prepare the long-delayed West Virginia-Virginia pipe for service. The venture was on track to complete the $7.85 billion project by the end of May, U.S. energy...
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing
May 10, 2024
03:32 PM EDT, 05/10/2024 (MT Newswires) -- Brett Sandercock, Chief Financial Officer, on May 08, 2024, sold 13,000 shares in Resmed ( RMD ) for $2,747,810. Following the Form 4 filing with the SEC, Sandercock has control over a total of 92,056 shares of the company, with 92,056 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943819/000112760224014978/xslF345X03/form4.xml Price: 214.16, Change: -2.69, Percent Change:...
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone
May 10, 2024
03:32 PM EDT, 05/10/2024 (MT Newswires) -- Alpine Immune Sciences ( ALPN ) and Vertex Pharmaceuticals ( VRTX ) said Friday the waiting period under the Hart-Scott-Rodino antitrust act related to their merger deal expired Thursday. Vertex has agreed to acquire Alpine for $4.9 billion in cash, or $65 a share. Price: 64.94, Change: +0.12, Percent Change: +0.19 ...
Market Chatter: Cipla Open to Partner With Eli Lilly to Market Obesity Drugs in India
Market Chatter: Cipla Open to Partner With Eli Lilly to Market Obesity Drugs in India
May 10, 2024
03:45 PM EDT, 05/10/2024 (MT Newswires) -- Eli Lilly ( LLY ) could partner with Indian drugmaker Cipla to market its weight-loss drugs in India, Reuters reported Friday, citing Cipla's Global CEO Umang Vohra. Cipla has an existing partnership to distribute and market Lilly's diabetes medicines in India, according to the report. Global demand for Eli Lilly's ( LLY )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved